Ownership history in NVIDIA CORP · 8 quarters on record
This page tracks every 13F SEC filing in which NVIDIA CORP reported a position in RECURSION PHARMACEUTICALS IN (RXRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 7,706,363 | — | 0% | 0.98% | $37.6M | $4.88 |
| 2025 Q2 | UNCHANGED | 7,706,363 | — | 0% | 0.90% | $39.0M | $5.06 |
| 2025 Q1 | UNCHANGED | 7,706,363 | — | 0% | 3.55% | $40.8M | $5.29 |
| 2024 Q4 | UNCHANGED | 7,706,363 | — | 0% | 17.11% | $52.1M | $6.76 |
As of 2025 Q4 — sorted by position size